NVUS (NVUS) Stock Price, News & Analysis

Name: NVUS (NVUS) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

NVUS NASDAQ

Company Description

NVUS (NASDAQ: NVUS) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for NVUS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

Last updated:

Performance 1 year

Market Cap

Shares outstanding

Latest News

View All

January 4, 2021

-5.19%

Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook

December 22, 2020

-2.94%

Novus Therapeutics Announces Results of Special Meeting of Stockholders

December 9, 2020

+0.25%

Novus Therapeutics Appoints June Lee, M.D., to Board of Directors

management

November 16, 2020

-5.02%

Novus Therapeutics Reports Third Quarter 2020 Financial Results

earnings

November 10, 2020

-0.31%

Novus Therapeutics to Release Third Quarter 2020 Financial Results on Monday, November 16

earnings

October 2, 2020

-5.56%

Novus Therapeutics Announces One-for-Eighteen Reverse Stock Split

stock split

NVUS has 6 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 5 with negative movement. Key topics include management, earnings, stock split. View all NVUS news →

SEC Filings

View All

No SEC filings available for NVUS.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

NVUS Company Profile & Sector Positioning

NVUS (NVUS) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.